Official Trial Name: The Genomic, Epigenomic, and Psychosocial Characteristics of Long-Term Survivors of Ovarian Cancer – Recruitment. Some advanced-stage ovarian cancer patients are long-term survivors of stages III and IV serum ovarian cancer. These patients may provide the key to long-term survival and bring hope to all women with Stages III and IV ovarian cancer. … Continued
(February 24, 2016) Research led by Dr. Elizabeth Swisher at the University of Washington, funded in part by OCRFA and published this month in JAMA Oncology, shows that mutations in the gene PPM1D in women with ovarian cancer are the result of aging and chemotherapy exposure. Read the abstract in JAMA Oncology. Previously, somatic mosaic … Continued
The Ovarian Cancer Research Alliance provides information based on medical research and best practices. Research regarding a connection between the use of talcum powder and increased ovarian cancer risk is inconclusive. The verdict of a recent trial regarding talcum powder. will not change the information that the Ovarian Cancer Research Alliance provides to women about talcum … Continued
(February 22, 2016) Imagine a lighthouse on cancer cells that can tell the T-cells in our immune system precisely where to attack to stop cancer in its tracks. When working properly, that’s exactly what dendritic cells do. They break down cancer cells into antigens that T-cells can “read” and know to attack while sparing healthy … Continued
Check out our webinar by Chad Ramsey, VP of Policy, and Alison Silberman, Director of Field Engagement, to learn about OCRFA’s legislative efforts in 2016. You’ll hear about the issues we are working on and learn about ways you can get involved to help make a difference for women with ovarian cancer. Watch more webinars.
In his final State of the Union address, President Obama announced a national initiative to find a cure to cancer. Details are beginning to emerge about the plan and the President has requested $1 Billion in new funding over the next two years to boost the effort. As Congress begins to consider annual appropriations legislation, … Continued
The Sandy Rollman Ovarian Cancer Foundation (SROCF) humbly began 15 years ago, on a living room floor, with the goal to give women a fighting chance against ovarian cancer. At the heart of the foundation is Sandy Rollman, a remarkable woman who lost her battle to ovarian cancer in 2000 at far too young an … Continued
As of January 2016, we are pleased to announce we are joining together to form Ovarian Cancer Research Alliance (OCRFA), the largest global organization dedicated to advancing ovarian cancer research while supporting women and their families.
(January 27, 2016) A new study of 8,000 women reported in the Journal of the National Cancer Institute reports that carrying mutations in a gene called BRIP1 raised a woman’s chance of getting ovarian cancer in her lifetime to approximately 5%– nearly three times greater than chance women generally have of developing the cancer. Around … Continued
The Ovarian Cancer National Alliance and Ovarian Cancer Research Fund have led the way in advocacy, research and support for patients and their families for over 22 years. We are pleased to announce we are joining together to form Ovarian Cancer Research Alliance (OCRFA), the largest global organization dedicated to advancing ovarian cancer research while supporting … Continued
Merger to create largest global ovarian cancer policy advocacy and research organization January 26, 2016 — Today, two of the nation’s foremost ovarian cancer policy advocacy and research organizations, the Ovarian Cancer National Alliance and Ovarian Cancer Research Fund announced a merger, forming the Ovarian Cancer Research Alliance (OCRFA). This move comes at a critical … Continued
The 3rd Foodie Friday features Mystic Bourbon Liqueur located in North Carolina. This company was created by two husband and wife teams; Michael & Katie and Jonathan & Marla. The origin of Mystic can be traced back to when Katie discovered the secret on their kitchen stove top. Learn more about this mysterious creation at … Continued
Get email updates about research news, action alerts, and ways to join the fight.
